Clinical Guidelines and Best Practice
Essential guidelines and best practices for effective clinical decision-making

.png)





2018 Diabetes Canada Clinical Practice Guidelines
Note, this guideline has been updated and should be used for reference only. In 2018, Diabetes Canada Clinical Practice Guidelines Expert Committee have compiled a comprehensive clinical practice guideline for the prevention and management of diabetes in Canada.
Insulin Prescription Tool - Initiation & Titration Guide
Comprehensive insulin prescribing tool to guide optimal treatment decisions and streamline diabetes management. Please note that Levemir is anticipated to be discontinued at the end of 2025 - and this tool will need to be updated by Diabetes Canada.
Retinopathy Screening Guidelines
For individuals aged 15 and older with type 1 diabetes, annual retinopathy screening by a vision care professional should start 5 years after diagnosis; for type 2 diabetes, screening should begin at diagnosis, with follow-up based on severity. Effective blood glucose and blood pressure control, along with appropriate interventions, are crucial for managing and preventing retinopathy.
Inlow's 60-second Diabetic Foot Screening
Inlow's 60-second foot screening, provided by Wounds Canada, provides a rapid and effective assessment of foot health in just one minute. This tool allows healthcare professionals to quickly identify potential issues and take early action to prevent serious complications.
College of Physicians and Surgeons
The College of Physicians and Surgeons of BC establishes practice standards, professional guidelines, and legislative guidance to help physicians and surgeons uphold exceptional medical practice and conduct. These resources cover specific, relevant issues in medical practice and are regularly updated to reflect current standards. Registrants are encouraged to familiarize themselves with these documents and review them frequently to ensure they stay aligned with best practices.
Lifetime Prevention Schedule Guide 2023
The Lifetime Prevention Schedule (LPS) Practice Guide 2023 by the British Columbia government is a guideline for health professionals to prioritize preventive healthcare measures across a patient’s lifespan. It includes recommendations on screenings, behavioral interventions, and preventive medications tailored by age and sex. The guide emphasizes clinically effective and cost-efficient interventions that impact public health positively. The LPS is updated regularly to reflect current health needs and priorities in British Columbia.
GLP‑1 Therapy Guidelines & Resources




Lifestyle + GLP‑1 Therapy Benefits
A large meta‑analysis found that combining GLP‑1 receptor agonists with lifestyle modification led to significantly greater weight loss, improved waist circumference, better HbA1c, and favorable changes in blood lipids and blood pressure compared to lifestyle changes alone.
Practical Nutrition & Activity Tips
Experts emphasize protein intake (20–30 g per meal) to preserve lean mass, smaller regular meals to manage appetite and GI side effects, and a balanced, nutrient‑dense diet (whole grains, fiber, healthy fats). Hydration and gradual exercise progression support overall wellbeing on GLP‑1 therapies.
Lifestyle + GLP‑1 for Heart Health
Preliminary data presented at the American Heart Association Scientific Sessions 2025 shows that people with Type 2 Diabetes who combine GLP‑1 therapy with lifestyle improvements (healthy eating, activity) see greater reductions in cardiovascular risk compared to medication alone.
2023 AACE Consensus Statement
The American Association of Clinical Endocrinology / American College of Endocrinology consensus algorithm provides a comprehensive therapeutic framework for T2D, including the positioning of GLP‑1 receptor agonists within dual and triple therapy regimens and comorbidity‑based pathways.
Gastrointestinal Side Effect Management
This multidisciplinary expert guideline outlines practical strategies to reduce nausea, vomiting, diarrhea, and constipation that often occur during GLP‑1 therapy—especially during dose increases. It includes recommendations on dose escalation and symptom mitigation for patients.
Managing Common GLP-1 Side Effects
Many people experience nausea, vomiting, diarrhea, or constipation when starting GLP‑1 or combination therapies. Simple strategies can help: eat small, frequent meals and avoid greasy or spicy foods to reduce nausea; stay well hydrated and adjust food quality to manage vomiting.
